Breastcancer.org Podcast

340 Avsnitt

1. Trodelvy Offers Benefits for Hormone Receptor-Positive Breast Cancer

   Publicerades: 2022-09-21
2. Enhertu for HER2-Low Breast Cancer: Patient-Reported Outcomes

   Publicerades: 2022-09-14
3. Mental Health Benefits of Pets

   Publicerades: 2022-08-19
4. How Therapy Can Help People Affected by Breast Cancer

   Publicerades: 2022-08-05
5. Fezolinetant: A Non-Hormonal Treatment for Hot Flashes

   Publicerades: 2022-07-22
6. Enhertu for HER2-Low Breast Cancer

   Publicerades: 2022-07-08
7. Loosening COVID-19 Restrictions and Immunocompromised People: Do You Feel Left Behind?

   Publicerades: 2022-06-24
8. Genetic and Genomic Tests: What’s the Difference?

   Publicerades: 2022-06-02
9. Just Ask: Increasing Diversity in Clinical Trials

   Publicerades: 2022-05-27
10. Dating and Breast Cancer

    Publicerades: 2022-04-29
11. Adolescent and Young Adult Breast Cancer

    Publicerades: 2022-03-28
12. Top Research Presented at the 2021 San Antonio Breast Cancer Symposium

    Publicerades: 2021-12-21
13. Aromatase Inhibitors versus Tamoxifen for Pre-Menopausal Women Diagnosed With Early-Stage, Hormone Receptor-Positive Disease

    Publicerades: 2021-12-13
14. Experimental Elacestrant: A Standard of Care for Pre-Treated, Metastatic, Hormone Receptor-Positive, HER2-Negative Breast Cancer?

    Publicerades: 2021-12-11
15. Alcohol and Breast Cancer Risk

    Publicerades: 2021-11-05
16. Breast Cancer Research at ESMO 2021

    Publicerades: 2021-10-21
17. Kisqali Plus Femara Seems Best Option for Advanced-Stage Hormone-Receptor-Positive HER2-Negative Breast Cancer

    Publicerades: 2021-10-01
18. Keytruda Added to Chemotherapy Improves Overall Survival for Metastatic PD-L1-Positive, Triple-Negative Breast Cancer

    Publicerades: 2021-09-24
19. The Importance of Diversity in Breast Cancer Clinical Trials

    Publicerades: 2021-09-15
20. Tattoo Ink Showing Up on Mammograms

    Publicerades: 2021-08-20